Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 4;12(6):e00348.
doi: 10.14309/ctg.0000000000000348.

Low-Grade Endotoxemia and Thrombosis in COVID-19

Affiliations

Low-Grade Endotoxemia and Thrombosis in COVID-19

Alessandra Oliva et al. Clin Transl Gastroenterol. .

Abstract

Introduction: Patients with community-acquired pneumonia display enhanced levels of lipopolysaccharides (LPS) compared with controls, suggesting that low-grade endotoxemia may be implicated in vascular disturbances. It is unknown whether this occurs in patients with coronavirus 2019 (COVID-19) and its impact on thrombotic complications.

Methods: We measured serum levels of zonulin, a marker of gut permeability, LPS, and D-dimer in 81 patients with COVID-19 and 81 healthy subjects; the occurrence of thrombotic events in COVID-19 during the intrahospital stay was registered.

Results: Serum LPS and zonulin were higher in patients with COVID-19 than in control subjects and, in COVID-19, significantly correlated (R = 0.513; P < 0.001). Among the 81 patients with COVID-19, 11 (14%) experienced thrombotic events in the arterial (n = 5) and venous circulation (n = 6) during a median follow-up of 18 days (interquartile range 11-27 days). A logistic regression analysis showed that LPS (P = 0.024) and D-dimer (P = 0.041) independently predicted thrombotic events.

Discussion: The study reports that low-grade endotoxemia is detectable in patients with COVID-19 and is associated with thrombotic events. The coexistence of low-grade endotoxemia with enhanced levels of zonulin may suggest enhanced gut permeability as an underlying mechanism.

PubMed Disclaimer

Conflict of interest statement

Guarantor of the article: Francesco Violi, MD.

Specific author contributions: Alessandra Oliva, MD, and Vittoria Cammisotto, MSc, equally contributed. A.O.: study design and coordination. V.C.: laboratory analysis. R.C.: statistical analysis and draft elaboration. D.F.: patients' recruitment and follow-up. M.C.M., M.D.A., and F.C.: laboratory analysis. P.P.: data interpretation and draft elaboration. M.V., F.P., and C.M.M.: data interpretation and article elaboration. F.V.: study conception and coordination, data interpretation, and writing the manuscript.

Financial support: This research was funded by grant from PhD course: Fisiopatologia Ed Imaging Cardio-Toraco-Vascolare, Sapienza University of Rome.

Potential competing interests: None to report.

Figures

Figure 1.
Figure 1.
Scatter plot showing significant (2-tailed) Spearman positive correlation of zonulin in horizontal vs vertical directions of LPS concentration.
Figure 2.
Figure 2.
TIRAP phosphorylation (n = 21, a), MyD88 and TIRAP co-immunoprecipitation (n = 12, c) in patients with COVID-19 and HS. Data are expressed as mean values ± SDs and *P < 0.05. Representative western blot bands of TIRAP phosphorylation and immune complexes TIRAP/MyD88 (b and d). TIRAP, Toll/interleukin-1 receptor domain-containing adapter protein. A.U., arbitrary unit; HS, Healthy subjects; MyD88, Myeloid differentiation factor 88.

Comment in

References

    1. Bilaloglu S, Aphinyanaphongs Y, Jones S, et al. . Thrombosis in hospitalized patients with COVID-19 in a New York City Health System. JAMA 2020;324:799–801. - PMC - PubMed
    1. Bikdeli B, Madhavan MV, Jimenez D, et al. . COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol 2020;75:2950–73. - PMC - PubMed
    1. Cangemi R, Della Valle P, Calvieri C, et al. . Low-grade endotoxemia and clotting activation in the early phase of pneumonia. Respirology 2016;21:1465–71. - PubMed
    1. Cangemi R, Casciaro M, Rossi E, et al. . Platelet activation is associated with myocardial infarction in patients with pneumonia. J Am Coll Cardiol 2014;64:1917–25. - PubMed
    1. Carnevale R, Sciarretta S, Valenti V, et al. . Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: Implication for myocardial infarction. Eur Heart J 2020;41:3156–65. - PubMed

Publication types

MeSH terms